Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AGENUS INCAGEN · Entity 5774 | Director | October 01, 2026 | October 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AGENUS INC
Report date October 01, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 29,807.791 |
Reported balance
After 2026-10-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 1,178.764 · Balance 29,807.791 F1: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3: $6.893 per Deferred Stock Unit acquired on October 1, 2026. The price of each Deferred Stock Unit acquired on October 1, 2026 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.
F2: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.
F3: $6.893 per Deferred Stock Unit acquired on October 1, 2026. The price of each Deferred Stock Unit acquired on October 1, 2026 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 2, 2026 23:24 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 1,178.764 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-412050 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,807.791 Underlying: Common Stock · 1,178.764 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $6.893 per Deferred Stock Unit acquired on October 1, 2026. The price of each Deferred Stock Unit acquired on October 1, 2026 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| August 05, 2026 Filed Aug 7, 2026 18:33 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 50,000 | $0.00 Strike: $7.78 | $0.00 |
DisclosureSEC source: 0001193125-26-340007 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2036-08-05 F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter. Read SEC document |
| July 01, 2026 Filed Jul 7, 2026 14:39 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 2,267.765 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-297088 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,180.771 Underlying: Common Stock · 2,267.765 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.583 per Deferred Stock Unit acquired on July 1, 2026. The price of each Deferred Stock Unit acquired on July 1, 2026 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 20:15 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 105,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0001193125-26-187081 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2036-04-24 F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests on the one-year anniversary of the grant date. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:30 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 2,448.256 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-140270 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,361.262 Underlying: Common Stock · 2,448.256 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.319 per Deferred Stock Unit acquired on April 1, 2026. The price of each Deferred Stock Unit acquired on April 1, 2026 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 2,040.576 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-002391 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,913.006 Underlying: Common Stock · 2,040.576 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.982 per Deferred Stock Unit acquired on January 2, 2026. The price of each Deferred Stock Unit acquired on January 2, 2026 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 1,704.928 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-230086 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,872.43 Underlying: Common Stock · 1,704.928 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $5.01 per Deferred Stock Unit acquired on July 1, 2025. The price of each Deferred Stock Unit acquired on October 1, 2025 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 20:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 2,707.834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-093835 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,167.502 Underlying: Common Stock · 2,707.834 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.462 per Deferred Stock Unit acquired on July 1, 2025. The price of each Deferred Stock Unit acquired on July 1, 2025 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:10 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 15,000 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0000950170-25-088505 · ownership.xml · derivative · entry 2 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2035-05-28 F2 · derivative.exercise_date: Options were granted on May 28, 2025 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 17, 2025. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests on the one-year anniversary of the grant date. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:10 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 750 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0000950170-25-088505 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 750 shares Expires 2035-05-28 F1 · derivative.exercise_date: Options were granted on May 28, 2025 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 17, 2025. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on May 28, 2026, and the balance vesting in equal quarterly installments thereafter. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 20:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 3,255.585 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-049296 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,459.668 Underlying: Common Stock · 3,255.58 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $2.88 per Deferred Stock Unit acquired on April 1, 2025. The price of each Deferred Stock Unit acquired on April 1, 2025 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| January 02, 2025 Filed Jan 2, 2025 21:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 2,532.661 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-000406 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,204.083 Underlying: Common Stock · 2,532.661 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.70 per Deferred Stock Unit acquired on January 2, 2025. The price of each Deferred Stock Unit acquired on January 2, 2025 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 12:39 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 1,252.492 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-112006 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,671.423 Underlying: Common Stock · 1,252.492 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $7.49 per Deferred Stock Unit acquired on October 1, 2024. The price of each Deferred Stock Unit acquired on October 1, 2024 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| July 01, 2024 Filed Jul 1, 2024 20:09 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 776.019 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-079598 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,418.931 Underlying: Common Stock · 776.019 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $12.08 per Deferred Stock Unit acquired on July 1, 2024. The price of each Deferred Stock Unit acquired on July 1, 2024 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 11, 2024 Filed Jun 18, 2024 20:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 750 | $0.00 Strike: $13.25 | $0.00 |
DisclosureSEC source: 0000950170-24-074838 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 750 shares Expires 2034-01-26 F1 · derivative.exercise_date: Options were granted on January 26, 2024 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 11, 2024. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on January 26, 2025 and the balance vesting in equal quarterly installments thereafter. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 15,000 Stock Options with an exercise price of $0.66. Read SEC document |
| April 01, 2024 Filed Apr 1, 2024 21:06 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 14,134.924 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-039491 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,858.238 Underlying: Common Stock · 14,134.924 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $0.66 per Deferred Stock Unit acquired on April 1, 2024. The price of each Deferred Stock Unit acquired on April 1, 2024 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| February 05, 2024 Filed Apr 22, 2024 20:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 7,500 | $0.00 Strike: $12.60 | $0.00 |
DisclosureSEC source: 0000950170-24-046418 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2034-02-05 F1 · derivative.exercise_date: The Stock Options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan on February 5, 2024 and will vest on February 5, 2025. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 150,000 Stock Options with an exercise price of $0.63. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 11:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 11,325.503 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-001477 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,723.314 Underlying: Common Stock · 11,325.503 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $0.83 per Deferred Stock Unit acquired on January 2, 2024. The price of each Deferred Stock Unit acquired on January 2, 2024 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| November 03, 2023 Filed Feb 12, 2024 12:00 UTC | AGENUS INC AGEN · Entity 5774 | OtherCommon Stock | 5,000 | $0.88 | $4,400.00 |
DisclosureSEC source: 0000950170-24-013559 · ownership.xml · nonDerivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,391 F1 · shares: Represents open market purchase of common stock for cash. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 21:12 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 6,585.751 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-051971 · ownership.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,397.81 Underlying: Common Stock · 6,585.751 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $1.42 per Deferred Stock Unit acquired on October 2, 2023. The price of each Deferred Stock Unit acquired on October 2, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. This amount also includes a downward adjustment of 27.45 Deferred Stock Units in respect of the grant dated July 3, 2023, as the average closing price used for such calculation incorrectly reflected a stock split and was increased on October 2, 2023 to $1.61 per Deferred Stock Unit. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| July 03, 2023 Filed Jul 6, 2023 20:30 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 5,860.362 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-017126 · doc4.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,812.055 Underlying: Common Stock · 5,860.362 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $1.60 per Deferred Stock Unit acquired on July 3, 2023. The price of each Deferred Stock Unit acquired on July 3, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| April 03, 2023 Filed Apr 3, 2023 19:58 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 4,354.259 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-010206 · doc4.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,951.693 Underlying: Common Stock · 4,354.259 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $2.153 per Deferred Stock Unit acquired on April 3, 2023. The price of each Deferred Stock Unit acquired on April 3, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| January 08, 2023 Filed Jan 10, 2023 00:07 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 150,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0000899243-23-001362 · doc4.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-01-08 F1 · derivative.exercise_date: Options of Common Stock were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan (the "2019 Plan") on January 8, 2023. Options will vest on January 8, 2024. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 16:15 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 3,619.691 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-000498 · doc4.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,597.434 Underlying: Common Stock · 3,619.691 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $2.590 per Deferred Stock Unit acquired on January 3, 2023. The price of each Deferred Stock Unit acquired on January 3, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 17:10 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 3,608.154 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-032921 · doc4.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,977.743 Underlying: Common Stock · 3,608.154 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $2.598 per Deferred Stock Unit acquired on October 3, 2022. The price of each Deferred Stock Unit acquired on October 3, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 19:52 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 5,068.893 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-025326 · doc4.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,369.589 Underlying: Common Stock · 5,068.893 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $1.85 per Deferred Stock Unit acquired on July 1, 2022. The price of each Deferred Stock Unit acquired prior to July 1, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 22:39 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 3,405.296 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-013874 · doc4.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,300.696 Underlying: Common Stock · 3,405.296 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $2.753 per Deferred Stock Unit acquired on April 1, 2022. The price of each Deferred Stock Unit acquired prior to April 1, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 23:16 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.39 | $0.00 |
DisclosureSEC source: 0000899243-22-005255 · doc4.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2032-02-04 F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan, as amended, and will vest on February 4, 2023. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 20:10 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 2,338.533 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-000853 · doc4.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,895.4 Underlying: Common Stock · 2,338.533 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $4.009 per Deferred Stock Unit acquired on January 3, 2022. The price of each Deferred Stock Unit acquired prior to January 3, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 23:19 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 1,628.532 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-039313 · doc4.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,556.867 Underlying: Common Stock · 1,628.532 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $5.757 per Deferred Stock Unit acquired on October 1, 2021. The price of each Deferred Stock Unit acquired prior to October 1, 2021 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 21:56 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 2,453.883 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-027301 · doc4.xml · derivative · entry 2 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,928.335 Underlying: Common Stock · 2,453.883 shares Expires not disclosed F2 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F4 · price: $3.820 per Deferred Stock Unit acquired on July 1, 2021. The price of each Deferred Stock Unit acquired prior to July 1, 2021 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan F3 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F3 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:57 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 20,501 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0000899243-21-025015 · doc4.xml · derivative · entry 3 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,501 Underlying: Common Stock · 20,501 shares Expires 2031-06-16 F3 · security: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:57 UTC | AGENUS INC AGEN · Entity 5774 | GrantRestricted Stock Unit · Derivative | 12,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-025015 · doc4.xml · derivative · entry 2 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires not disclosed F2 · derivative.exercise_price: On June 16, 2021, Mr. Wright was granted 12,000 Restricted Stock Unitsas part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2022, subject to Mr. Wright's continued service on the Board of Directors through such date. F2 · shares: On June 16, 2021, Mr. Wright was granted 12,000 Restricted Stock Unitsas part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2022, subject to Mr. Wright's continued service on the Board of Directors through such date. F2 · price: On June 16, 2021, Mr. Wright was granted 12,000 Restricted Stock Unitsas part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2022, subject to Mr. Wright's continued service on the Board of Directors through such date. F2 · derivative.exercise_date: On June 16, 2021, Mr. Wright was granted 12,000 Restricted Stock Unitsas part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2022, subject to Mr. Wright's continued service on the Board of Directors through such date. F2 · derivative.expiration_date: On June 16, 2021, Mr. Wright was granted 12,000 Restricted Stock Unitsas part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2022, subject to Mr. Wright's continued service on the Board of Directors through such date. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:57 UTC | AGENUS INC AGEN · Entity 5774 | Exercise / conversionCommon Stock | 16,853 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-025015 · doc4.xml · nonDerivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 16, 2020, Mr. Wright was granted 16,853 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 16, 2021, this award vested in full and Mr. Wright was issued the underlying 16,853 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan. F1 · price: On June 16, 2020, Mr. Wright was granted 16,853 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 16, 2021, this award vested in full and Mr. Wright was issued the underlying 16,853 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan. Read SEC document |
| June 15, 2021 Filed Jul 2, 2021 21:56 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option · Derivative | 100,000 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0000899243-21-027301 · doc4.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-12-17 F1 · derivative.exercise_date: Option was granted on January 1, 2021, subject to shareholder approval of an increase to the available pool under the Company's 2019 Equity Incentive Plan ("2019 Plan"), which was obtained at the Company's annual shareholder meeting on June 15, 2021. Option awarded in accordance with the 2019 Plan. Option vests in full on December 17, 2022. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:40 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 2,546.307 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-21-000016 · primary_doc.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,474.452 Underlying: Common Stock · 2,546.307 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.682 per Deferred Stock Unit acquired on April 1, 2021. The price of each Deferred Stock Unit acquired prior to April 1, 2021 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 22:02 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 2,149.204 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-21-000003 · primary_doc.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,928.145 Underlying: Common Stock · 2,149.204 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.780 per Deferred Stock Unit acquired on January 4, 2021. The price of each Deferred Stock Unit acquired prior to January 4, 2021 is the average of the closing price for the Company's Common Stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's Common Stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's Common Stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 19:52 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option (Right to buy) · Derivative | 100,000 | $0.00 Strike: $3.70 | $0.00 |
DisclosureSEC source: 0001745285-20-000052 · primary_doc.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-12-17 F1 · derivative.exercise_date: Stock Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The Stock Option vests in full on December 17, 2021 (provided Mr. Wright continues to serve on the board on such date). Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 18:29 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 2,049.746 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-20-000033 · primary_doc.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,778.941 Underlying: Common Stock · 2,049.746 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.964 per Deferred Stock Unit acquired on October 1, 2020. The price of each Deferred Stock Unit acquired prior to October 1, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| July 01, 2020 Filed Jul 1, 2020 23:18 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 2,662.826 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-20-000025 · primary_doc.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,729.195 Underlying: Common Stock · 2,662.826 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.051 per Deferred Stock Unit acquired on July 1, 2020. The price of each Deferred Stock Unit acquired prior to July 1, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 20:49 UTC | AGENUS INC AGEN · Entity 5774 | Exercise / conversionRestricted Stock Unit · Derivative | 20,338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-20-000022 · primary_doc.xml · derivative · entry 2 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,338 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On June 19, 2019, Mr. Wright was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wright was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan. F1 · price: On June 19, 2019, Mr. Wright was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wright was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan. F1 · derivative.exercise_date: On June 19, 2019, Mr. Wright was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wright was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan. F1 · derivative.expiration_date: On June 19, 2019, Mr. Wright was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wright was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan. Read SEC document |
| June 19, 2020 Filed Jun 23, 2020 20:49 UTC | AGENUS INC AGEN · Entity 5774 | Exercise / conversionCommon Stock | 20,338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-20-000022 · primary_doc.xml · nonDerivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 19, 2019, Mr. Wright was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wright was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan. F1 · price: On June 19, 2019, Mr. Wright was granted 20,338 Restricted Stock Units as part of his annual compensation for service on the Executive Committee of the Agenus Inc. Board of Directors. On June 19, 2020, this award vested in full and Mr. Wright was issued the underlying 20,338 shares of common stock, all in accordance with the Agenus Inc. 2019 Equity Incentive Plan. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 21:43 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option (Right to buy) · Derivative | 2,500 | $0.00 Strike: $3.56 | $0.00 |
DisclosureSEC source: 0001745285-20-000017 · primary_doc.xml · derivative · entry 2 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2030-06-16 F3 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan and will vest on June 16, 2021. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 21:43 UTC | AGENUS INC AGEN · Entity 5774 | GrantRestricted Stock Unit · Derivative | 16,853 | $0.00 | $0.00 |
DisclosureSEC source: 0001745285-20-000017 · primary_doc.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,191 Underlying: Common Stock · 16,853 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 16, 2021. F1 · derivative.expiration_date: Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 16, 2021. F2 · balance_after: Includes 20,338 Restricted Stock Units that are scheduled to vest on June 19, 2020. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 18:51 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 2,539.446 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-20-000003 · primary_doc.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,066.369 Underlying: Common Stock · 2,539.446 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.200 per Deferred Stock Unit acquired on April 1, 2020. The price of each Deferred Stock Unit acquired prior to April 1, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:28 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 2,285.296 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-000514 · doc4.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,526.923 Underlying: Common Stock · 2,285.296 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $3.419 per Deferred Stock Unit acquired on January 2, 2020. The price of each Deferred Stock Unit acquired prior to January 2, 2020 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| December 24, 2019 Filed Dec 27, 2019 21:30 UTC | AGENUS INC AGEN · Entity 5774 | GrantStock Option (Right to buy) · Derivative | 75,000 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000899243-19-030114 · doc4.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-12-24 F1 · derivative.exercise_date: Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan and will vest on December 24, 2020. Read SEC document |
| October 01, 2019 Filed Oct 1, 2019 18:58 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 2,865.822 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001745285-19-000014 · primary_doc.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,241.627 Underlying: Common Stock · 2,865.822 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $2.726 per Deferred Stock Unit acquired on October 1, 2019. The price of each Deferred Stock Unit acquired prior to October 1, 2019 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 10:05 UTC | AGENUS INC AGEN · Entity 5774 | GrantDeferred Stock Units · Derivative | 2,806.886 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-018768 · doc4.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,375.805 Underlying: Common Stock · 2,806.886 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis. F3 · price: $2.783 per Deferred Stock Unit acquired on July 1, 2019. The price of each Deferred Stock Unit acquired prior to July 1, 2019 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Units were acquired pursuant to the Agenus Inc. Director Deferred Compensation Plan, as amended. F2 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F2 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 19, 2019 Filed Jun 21, 2019 21:26 UTC | AGENUS INC AGEN · Entity 5774 | GrantRestricted Stock Unit · Derivative | 20,338 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-017831 · doc4.xml · derivative · entry 3 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,338 Underlying: Common Stock · 20,338 shares Expires not disclosed F2 · derivative.exercise_price: Restricted Stock Unit was granted on June 19, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Restricted Stock Unit awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 19, 2020. F2 · price: Restricted Stock Unit was granted on June 19, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Restricted Stock Unit awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 19, 2020. F2 · derivative.expiration_date: Restricted Stock Unit was granted on June 19, 2019, subject to shareholder approval of the Company's 2019 Equity Incentive Plan, which was obtained at the Company's annual shareholder meeting on June 19, 2019. Restricted Stock Unit awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests on June 19, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.